iomeprol has been researched along with Alloxan Diabetes in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordaro, M | 1 |
| Impellizzeri, D | 1 |
| Bruschetta, G | 1 |
| Siracusa, R | 1 |
| Crupi, R | 1 |
| Di Paola, R | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 1 |
1 other study available for iomeprol and Alloxan Diabetes
| Article | Year |
|---|---|
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy.
Topics: Acute-Phase Proteins; Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Ur | 2016 |